› Forums › General Melanoma Community › 4 infusions keytruda
- This topic has 4 replies, 3 voices, and was last updated 6 years, 2 months ago by
Mark_DC.
- Post
- Replies
-
-
- March 11, 2019 at 2:10 am
Anti- PD-1 products – either Keytruda (pembrolizumab) or Opdivo (nivolizumab) – have a roughly 40% response rate. The ipi/nivo combo has a roughly 50+% response rate. The chart included in this post notes that while responses to immunotherapy most often occur around 3 months into therapy, some may not occur until 6 – 10 months out:
With immunotherapy we have to remember to be "patient with the patient". Hope this helps. Celeste
-
- March 11, 2019 at 2:39 pm
Sometimes big tumors have big strength, and high dose radiotherapy can help imunotherapy to beat it. Try to find informations about combination of high dose radiotherapy and imunotherapy on the Internet.
It didn’t work in our case but I saw many case when it worked. -
- March 12, 2019 at 1:23 am
I dont konw how bad your starting point is but no change can mean stable disease which buys time and could be a sign something is working. What does your oncologist say? In my case they gave it nine months to one year before changing course. In my case adding TVEC to keytruda helped – i think some clinical trials with this are now starting. Good luck I know staying patient is far from easy
Mark
-
- You must be logged in to reply to this topic.